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Background: Malignant glaucoma is an ocular emergency and may lead to blindness if not 
promptly recognized and treated effectively. It is usually reported after trabeculectomy, and 
spontaneous or bilateral cases are not common in the literature.  
Case report: This article reports the case of a Nigerian woman who developed spontaneous 
bilateral malignant glaucoma with resultant visual impairment. A literature review on the subject is 
also undertaken. Possible etiology and management challenges of the case are also discussed.  
Conclusion: This study is aimed at drawing attention to this potentially blinding eye disease, and 
ultimately improves knowledge on its diagnosis and management, to reduce the visual morbidity. 
 




The term malignant glaucoma was first used by Von Graefe1 in 1869, to describe an ocular condition 
characterized by elevated intraocular pressure (IOP), a shallow or flat AC, in the presence of a patent 
iridectomy. This was in post trabeculectomy patients. It is also been called aqueous misdirection, 
ciliary block, cilio-vitreal block, and cilio-lenticular block glaucoma, in recognition of the possible 
aetiopathogenesis of this disease entity.  However, this definition has evolved over the years, and 
malignant glaucoma now includes a range of secondary angle closure glaucomas, unresponsive to 
conventional anti-glaucoma therapies2. The term “malignant” however, does not connote a neoplastic 
process. The most common scenario for malignant glaucoma is post trabeculectomy3-5, however, 
association with other clinical conditions have been reported. These include; cataract surgery with or 
without insertion of intraocular lens (IOL)6, laser iridotomy7,  miotic therapy8, glaucoma drainage 
tube implantation, insertion of a large IOL9, laser capsulotomy, intravitreal tramcinolone injection10, 
ocular keratomycosis, needling of a trabeculectomy bleb11 and acute hydrops in Down syndrome 
patients with keratoconus. 
 
In as much as the precipitating factors can be recognized as highlighted above, there are instances 
where is it difficult to pinpoint the triggering factor for malignant glaucoma. Reports of spontaneous 
malignant glaucoma are not common12,13 but reports from an African or Nigerian setting are very 
sparse. This article was aimed at reporting a case of presumed bilateral spontaneous malignant 
glaucoma in a Nigerian woman with resultant blindness, discuss the possible aetiology, and 




The patient was a 35 year old fashion designer who presented to our clinic with a three day history of 
blurring of vision and a two day history of complete loss of vision. There was associated ocular pain, 
redness and photophobia, with headaches. There was no history of nausea or vomiting. There was no 
history of ocular trauma or application of herbal or traditional eye medications. She was not a 
spectacle user and there was no other significant ocular history. She was not a known hypertensive or 
diabetic patient. 
 
 Five days prior to presentation, she delivered her second child via vacuum extraction at a private 
clinic. There was a history of post partum haemorrhage, necessitating transfusion of five pints of 
blood and admission in the private centre. Two days following delivery the patient noticed sudden 
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blurring of vision which deteriorated to complete loss of vision two days after. An eye doctor was said 
to have been called to review her by the private hospital after onset of ocular symptoms, who was said 
to have made a diagnosis of acute angle closure glaucoma and commenced her on some topical ocular 
medications. She was subsequently referred to our unit for further management, because there was no 
improvement in her ocular status.  
 
At presentation, she was pale, but not in any obvious distress, not febrile, and not jaundiced. Other 
systemic examinations were essentially normal. Ocular examination in both eyes revealed a visual 
acuity (VA) of no light perception (NPL), mild puffiness of the lids, conjuctival injection and 
chemosis, cornea edema and opacity with a peripheral circular and yellowish hue (Figure 1). The 




Figure 1. Photograph of Patient Showing Decompensated Cornea in Both Eyes. 
 
There was no view of the anterior chamber of the eyes or further ocular structures. Intra ocular 
pressure (IOP) measurement using hand held perkins applanation tonometer revealed a pressure of 
over 50mmgh in both eyes. A preliminary diagnosis of acute angle closure glaucoma with cornea 
decompensation was made at this point. 
 
The patient was commenced on Latanoprost and timolol eye drops and acetazolamide tablets to lower 
the IOP, ibuprofen eye drops to control ocular inflammation, and analgesics tablets. Intravenous 
mannitol 60mg over 20mins was also given. Examination of the packed cell volume (PCV) revealed 
15% value; patient was also requested to carry out an ocular ultrasound, and serial monitoring of the 
IOP was instituted. Haematinics were also commenced, and obstetrics consult was requested. 
However patient’s IOP did not respond significantly to antiglaucoma medication as the IOP remained 
above 50 mm Hg two days after admission. A diagnosis of malignant glaucoma was entertained at this 
point. Part of the line of management of obstetricians was a request that the patient be transfused.  
However, due to financial constraints, the patient opted to discharge herself two days after admission.  
Discussion 
 
Malignant glaucoma is a potentially blinding eye disease, if not promptly recognized and 
appropriately managed. Even though the definition by Von Graefe1 described a particular clinical 
scenario post trabeculectomy, the term malignant glaucoma as it is used now probably reflects the 
clinical course and prognosis and may not be restricted to a single disease entity. Consequently, 
malignant glaucoma has been associated with many secondary angle closure glaucomas resistant to 
conventional management protocols.  
 
The exact precipitating factor in this patient is not known, hence the presumed spontaneous 
terminology given to this case. One of the reasons for this is the late presentation to our facility. At the 
time of her presentation, vision in both eyes was already NPL, and the corneas were already 
 ISSN 2073-9990   East Cent. Afr. J. surg 
 
57 COSECSA/ASEA Publication  -East and Central African Journal of Surgery.  March/April 2014 Volume 19 (1)      
 
 
decompensated. This rendered further detailed ocular examination impossible. The persistently high 
IOP over a prolonged period had already caused end stage and irreversible damage to the optic nerve, 
as well as the cornea. The difficulty and resistance to conventional treatment modalities of malignant 
glaucoma was demonstrated in this case.  
 
The exact patho-physiology of malignant glaucoma is poorly understood, but the conventional believe 
is that of Shaffer14 who proposed that it is due to aqueous misdirection into the vitreous at the level of 
the ciliary body, lens and anterior vitreous face, with consequent  increase in vitreous volume and 
pressure. He coined the term ciliary block glaucoma. According to the work of Epstein et al15 it was 
postulated that there is additional thickening and decreased permeability of the anterior hyaloid 
surface, with limitation of anterior flow of aqueous humour into the anterior chamber. These lead to 
forward movement of the iris-lens diaphragm, shallowness of the anterior chamber, and secondary 
angle closure. However, Quigley16 had a contrary opinion on the pathway to the development of 
forward movement of the iris lens diaphragm and resultant angle closure. They contradicted the 
conventional idea of aqueous misdirection because it contravenes physical laws. They believe that for 
aqueous misdirection to occur, there needs to be a unidirectional valvular mechanism in place to 
prevent forward movement of the misdirected aqueous from the vitreous back into the posterior 
chamber,  but no such one way mechanism  has been found to exist at the anterior hyaloids surface. 
Quigley16 proposed two possible ocular conditions for the development of malignant glaucoma. They 
implicated choroidal expansion and abnormal vitreous fluid conductivity. Increases in orbital venous 
pressure and the volume of choroidal extra vascular space will produce choroidal expansion. The 
latter is thought to be more likely to be responsible for sustained choroidal expansion.   
 
This patient had a history of post partum haemorrhage, necessitating transfusion of seven pints of 
blood. It is not unlikely that this patient with a low socio-economic status might have had some 
underlining anaemia even during pregnancy. We postulate that this chronic aneamia, further 
complicated by acute blood loss might have precipitated extravasations of fluid into the extra vascular 
space, including the choroid. Another possibility in this patient is perhaps use of sulphonamide drugs. 
In the report by et al, the isolated malignant glaucoma was later found to have been precipitated by 
microspherophakia. 
 
The pathway to blindness in this patient (NPL in both eyes) was most likely optic neuropathy from the 
extremely high, sustained and uncontrolled IOP.  The decompensation of the cornea is also related to 
the high IOP. The poor visual prognosis of malignant glaucoma is well recognized. Unique features of 
this case were the bilateralism and absence of an apparent predisposing factor. Bilateral presentation 
of malignant glaucoma is not common17, and cases without an apparent precipitating factor18,19 are 
also rarer. To the best of our knowledge, this is the first report of such a case in Nigeria.   
 
At presentation, the aim of treatment of this patient was effective reduction of IOP, even though 
vision had been irreversibly affected. She was treated with topical (latanoprost, timolol) and systemic 
(oral acetazolamide and intravenous mannitol) IOP reducing drugs, as well as cycloplegic agents. 
However, these had little or no effect, as the IOP remained high for the two days she spent on 
admission. The difficulty in managing malignant glaucoma is well known2,20 and a significant 
proportion of patients might need surgical intervention18, 21 when medical treatment fails to bring 
about IOP reduction, through reduction in  aqueous production, vitreous shrinkage, widening of the 
ciliary ring, and eventual posterior movement of the iris lens diaphragm. However, medical treatment 
is usually the first line of management, and usually consists of: 
• Strong cycloplegic agents such as atropine, to paralyze the ciliary muscle, increase zonular 
tension, and cause flattening and posterior movement of the iris lens diaphragm, thereby 
opening up the anterior chamber angle. 
• Reduction of aqueous production using topical beta blockers (timolol), topical oral carbonic 
anhydrase inhibitors (acetazolamide), and alpha adrenergic agonist (brimonidine). 
• Osmotic agents (IV mannitol, oral glycerol or isosorbide) to shrink vitreous volume and 
encourage posterior movement of the iris lens diaphragm. 
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Overall, there is a reduction in IOP using a combination of the above regimen, and this is said to be 
effective in about 50% of patients22. A maintenance dose of atropine is said to be often required to 
prevent future recurence20 after gradual discontinuation of other drugs. However, some patients may 
not respond to medical therapy and surgical intervention may therefore be necessary. A commonly 
performed procedure is pars plana vitrectomy with or without lens extraction.23 Anterior 
hyaloidectomy in an aphakic or pseudophakic eye, lens extraction with anterior vitrectomy in a phakic 
eye, cyclodialysis, and posterior sclerostomy have also been used. Laser procedures found to be 
beneficial include; argon laser shrinkage of the ciliary processes24, ND-YAG laser capsulotomy and 
hyaloidotomy in aphakic or pseudophakic eyes25.  
 
The visual outcome in this patient resulting from prolonged uncontrolled raised IOP could perhaps 
have been prevented by an aggressive early intervention on prompt referral from the primary care 
givers. This highlights the need to ensure that general practitioners are able to recognize with ocular 
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